Citeer als: (2 december 2022) The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration. Geert De Vuyst. https://geertdevuyst.be/publicatie/2007-ashton-the-cannabinoid-cb2-receptor-as-a-target-for-inflammation-dependent-neurodegeneration/
The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
Artikel Engels Opgeleid
TitelThe Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent NeurodegenerationAuteur(s)Ashton, J., & Glass, M.PublicatieCurrent NeuropharmacologyVolume5Uitgave nummer2Publicatiejaar2007Pagina’s73-80DOIhttps://doi.org/10.2174/15701 ... UitgeverBentham Science Publishers Ltd.Citeer alsAshton, J., & Glass, M. (2007). The Cannabinoid CB2 Receptor as a Target for Inflammation‑Dependent Neurodegeneration. Current Neuropharmacology, 5(2), 73–80. https://doi.org/10.2174/157015907780866884